Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, compliance and secondary packaging services, has purchased three high speed blistering and cartoning lines with serialization and aggregation capabilities from McKesson RxPak’s production facility in Memphis. The infrastructure acquisition nearly doubles Legacy’s total blister production capacity, which now stands at half a billion packs per year.
In a separate equipment investment, this summer Legacy also will add an additional new high speed bottling line, bringing the contract packager’s bottling capacity to some 600 million units per year. Additionally, the company recently incorporated two new pouching machines to help meet growing demand for tablet and capsule filling applications.
The expansion-minded moves come amid recent growth in both the Rx and OTC sectors, and in expectation of continued heightened demand per the company’s transition into a high-volume, one-stop shop providing turnkey product packaging straight through market delivery.
Located in Memphis, McKesson RxPak is a division of McKesson Corp. and a leading provider of packaging products and services to manufacturers and retailers in the pharmaceutical industry. Michael Plumlee, Vice President of Sales “This will allow McKesson to focus on their portfolio expansion through their SKY Unit Dose Division.”
“This infrastructure investment is a natural evolution of the expansion plans Legacy adopted several years ago, starting with a 100,000-square-foot expansion in 2017 that added both production capabilities and warehousing capacity providing a total of 300,000 square feet,” said David Spence, CEO of Legacy Pharmaceutical Packaging. “Considering both recent growth, and that we anticipate more US base production moving forward, this was the right time to continue in a way that makes Legacy an even more versatile, dynamic and turnkey packaging partner.”
About Legacy Pharmaceutical Packaging, LCC
Legacy Pharmaceutical Packaging is a privately held contract pharmaceutical packaging company located in St. Louis, Missouri. Legacy is a full service pharma solution & medical device packaging provider servicing the branded, generic, government, wholesale and major retail markets. Legacy is registered with the FDA, VAWD accredited and licensed by the DEA to handle Schedule II-V drug products.
PLEASE NOTE: many 2020 events have been postponed / cancelled due to the worldwide COVID-19 Coronavirus pandemic. We recommend that you check directly with organisers to obtain the latest information on events of interest.
7th Brand Protection Excellence Forum (BPEF) 2020
June 04-05, 2020 - Munich, Germany
4th International Conference on Global Food Security
June 15-18, 2020 - Montpellier, France
4th GTDW Anti Illicit Trade & Brand Protection Technologies Conference
June 16-18, 2020 - Shanghai, China
Asia Security Conference & Exhibition
July 22-23, 2020 - Kuala Lumpur, Malaysia
International Food Fraud Conference
September 22-23, 2020 - Amsterdam, The Netherlands
Asian IP Forum (AIPF)
September 24-25, 2020 - Singapore
Global Brand Protection Summit 2020
September 24, 2020 - London, UK
European IP Forum
November 12-13, 2020 - Munich, Germany